Form D · Other
Genex Laboratories, LLC
Houston, TX · CIK 0001627446
Offering snapshot reported Dec 9, 2014 · SEC filing
- Reported sold
- $5K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $500 Reported outside-investor minimum
- First sale
- Nov 24, 2014 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 9, 2014 | Initial | $5,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-229767
Source: Form D, filed Dec 9, 2014. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joanna Davis | Director, Executive |
| N/A Excellence Medical Group, Llc | Executive |
| Francis R.M. Francis | Director, Executive |
| Bryan Lee | Director, Executive |
| Sherman Nagler | Director, Executive |
| Janell Russell | Director, Executive |
Issuer details
Industry: Other (See others in industry)
Address:
9301 Southwest Freeway Suite 255
Houston, TX, 77074-1510
Houston, TX, 77074-1510